<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">20272</article-id><article-id pub-id-type="doi">10.7554/eLife.20272</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Fatty acid analogue N-Arachidonoyl taurine restores function of I<sub>Ks</sub> channels with diverse long QT mutations</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-54058"><name><surname>Liin</surname><given-names>Sara I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8493-0114</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-55016"><name><surname>Larsson</surname><given-names>Johan E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55017"><name><surname>Barro-Soria</surname><given-names>Rene</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55021"><name><surname>Bentzen</surname><given-names>Bo Hjorth</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-10841"><name><surname>Larson</surname><given-names>H Peter</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Department of Physiology and Biophysics</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Clinical and Experimental Medicine</institution>, <institution>Linköping University</institution>, <addr-line><named-content content-type="city">Linköping</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff3"><institution content-type="dept">The Danish Arrhythmia Research Centre</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5115"><name><surname>Swartz</surname><given-names>Kenton J</given-names></name><role>Reviewing editor</role><aff><institution>National Institutes of Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>sara.liin@liu.se</email> (SL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>PLarsson@med.miami.edu</email> (HL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>09</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e20272</elocation-id><history><date date-type="received"><day>03</day><month>08</month><year>2016</year></date><date date-type="accepted"><day>28</day><month>09</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Liin et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Liin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-20272-v1.pdf"/><abstract><p>About 300 loss-of-function mutations in the I<sub>Ks</sub> channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved I<sub>Ks</sub> channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated I<sub>Ks</sub> channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in I<sub>Ks</sub> channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the I<sub>Ks</sub> channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future I<sub>Ks</sub> channel activators to treat Long QT syndrome caused by diverse I<sub>Ks</sub> channel mutations.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Xenopus</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01GM109762</award-id><principal-award-recipient><name><surname>Larson</surname><given-names>H Peter</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>14GRNT20380041</award-id><principal-award-recipient><name><surname>Larson</surname><given-names>H Peter</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003748</institution-id><institution>Svenska Sällskapet för Medicinsk Forskning</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Liin</surname><given-names>Sara I</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>524-2011-6806</award-id><principal-award-recipient><name><surname>Liin</surname><given-names>Sara I</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100003208</institution-id><institution>Northwest Lions Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Liin</surname><given-names>Sara I</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Sara I Liin, A patent application (62/032,739) based on these results has been submitted by the University of Miami with S.I.L. and H.P.L. identified as inventors.</p></fn><fn fn-type="conflict" id="conf3"><p>H Peter Larson, A patent application (62/032,739) based on these results has been submitted by the University of Miami with S.I.L. and H.P.L. identified as inventors.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Experiments were performed in strict accordance with the recommendations of The Linköping Animal Ethics Committee at Linköping University and The Animal Experiments Inspectorate under the Danish Ministry of Food, Agriculture and Fisheries. Protocols were approved by The Linköping Animal Ethics Committee at Linköping University (#53-13 ) and The Animal Experiments Inspectorate under the Danish Ministry of Food, Agriculture and Fisheries (University of Copenhagen; #2014-15-2934-01061).</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-20272-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>